Clinical trial
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal…
NCT00442416 · Hoffmann-La Roche, Industry · Terminated
Key facts
| NCT number | NCT00442416 |
|---|---|
| Title | A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients. |
| Official title | A Two-arm, Randomized, Open-label, Multicenter Study of Safety and Efficacy of Monthly Injections of RO0503821 Versus Epoetin Alfa in Peritoneal Dialysis Patients Who Self Inject or Receive In-center Injections. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Epoetin alfa, methoxy polyethylene glycol-epoetin beta [Mircera] |
| Enrollment | 80 |
| Start date | Feb 1, 2007 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Mar 2, 2007 |
| Last update posted | Aug 17, 2016 |
| Countries | United States |
At a glance
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: